XM Amerika Qoʻshma Shtatlari fuqarolariga xizmat koʻrsatmaydi.

Intuitive beats quarterly profit estimates on strong demand for surgical robots



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>UPDATE 1-Intuitive beats quarterly profit estimates on strong demand for surgical robots</title></head><body>

Adds outlook in paragraph 6, company comments in paragraph 7, background in paragraphs 8-9

By Mariam Sunny

Oct 17 (Reuters) -Medical device maker Intuitive Surgical ISRG.O beat Wall Street estimates for third-quarter profit on Thursday, helped by strong demand for its surgical robots used in minimally invasive procedures, sending shares up 6% in extended trading.

The company earned $1.84 per share on an adjusted basis for the quarter ended Sept. 30, beating analysts' average estimate of $1.63, according to data compiled by LSEG.

Medical device manufacturers have been benefiting from elevated demand for non-urgent surgeries as people, especially older Americans, catch up on procedures deferred during the pandemic.

Intuitive's surgical robots, da Vinci, are widely used for a range of procedures, including weight-loss surgeries and for conditions of the digestive system, bladder and heart.

Third-quarter volume of da Vinci procedures rose about 18% from a year ago, the company said.

Intuitive expects the volume of da Vinci procedures to grow between 16% and 17% this year, compared with the prior view of 15.5% to 17%.

The forecast does not reflect the significant impact to elective procedures due to the ongoing shortage of intravenous (IV) saline fluids or other hurricane-related effects, the company said on Thursday during the earnings call.

Production at Baxter International's BAX.N North Carolina plant, which makes 60% of the United States' supply of IV fluids and some key dialysis solutions, was closed late last month due to flooding caused by Hurricane Helene.

The shortage, triggered by this hit to production, is forcing hospitals to defer elective procedures and could hurt companies that make related medical devices, according to analysts.

Intuitive Surgical posted third-quarter revenue of $2.04 billion, in line with analyst estimates.

Sales at its instruments and accessories unit, which accounts for a major chunk of the revenue, rose 18% to $1.26 billion from a year ago, compared with estimates of $1.25 billion.



Reporting by Mariam Sunny in Bengaluru; Editing by Shreya Biswas

</body></html>

Javobgarlikdan voz kechish: XM Group korxonalari har biri faqat ijro xizmatlarini koʻrsatadi va onlayn savdo platformamizdan foydalanish huquqini beradi, bu odamga veb-saytda yoki veb-sayt orqali mavjud boʻlgan kontentni koʻrish va/yoki undan foydalanishga ruxsat beradi hamda uni oʻzgartirishga moʻljallanmagan va uni oʻzgartirmaydi yoki kengaytirmaydi. Bunday kirish va foydalanish huquqi doimo quyidagilarga boʻysunadi: (i) Shartlar va qoidalar; (ii) Risklar haqida ogohlantirish; va (iii) Javobgarlikni toʻliq rad etish. Shuning uchun bunday kontent umumiy maʼlumot sifatida taqdim etiladi. Xususan, shuni esda tutingki, bizning onlayn savdo platformamiz mazmuni moliyaviy bozorlarda biror bitimni amalga oshirishga oid maslahat yoki taklif emas. Har qanday moliyaviy bozorda savdo qilish sizning kapitalingiz uchun jiddiy risk darajasini oʻz ichiga oladi.

Onlayn savdo platformamizda chop etilgan barcha materiallar faqat taʼlim/axborot maqsadlari uchun moʻljallangan va unda moliyaviy, investitsiya soligʻi yoki savdo maslahatlari va tavsiyalar; yoki bizning savdo narxlarimizning qaydlari; yoki har qanday moliyaviy vositalar bilan bitim tuzish maslahati yoki taklifi; yoki sizga kerak boʻlmagan moliyaviy reklama aksiyalari hisoblanmaydi

Har qanday uchinchi tomon kontenti, shuningdek XM tomonidan tayyorlangan kontent, masalan: fikrlar, yangiliklar, tadqiqotlar, tahlillar, narxlar va boshqa maʼlumotlar yoki bu veb-saytda joylashgan uchinchi tomon saytlariga havolalar umumiy bozor sharhi sifatida "boricha" taqdim etiladi va investitsiya maslahatini tashkil etmaydi. Har qanday kontent investitsiya tadqiqoti sifatida talqin qilinsa, siz bunday kontentni investitsiya tadqiqotlarining mustaqilligini ragʻbatlantirish uchun moʻljallangan qonun talablariga muvofiq moʻljallanmagan va tayyorlanmaganligini eʼtiborga olishingiz va qabul qilishingiz kerak, shuning uchun unga tegishli qonunlar va qoidalarga muvofiq marketing kommunikatsiyasi sifatida qaraladi. Mustaqil boʻlmagan investitsiya tadqiqoti va yuqoridagi maʼlumotlarga oid risk haqida ogohlantirishimizni oʻqib chiqqaningizga va tushunganingizga ishonch hosil qiling, unga bu yerdan kirish mumkin.

Riskdan ogohlantirish: Kapitalingiz risk ostida. Kredit yordamiga ega mahsulotlar hammaga ham toʻgʻri kelmasligi mumkin. Bizning Risklardan ogohlantirishimiz bilan tanishib chiqing.